Earnings Call · Q1 FY2026·2025-10-30

Q1 26EPS +1.03%·Rev n/aQ4 25EPS +2.95%·Rev n/aQ3 25EPS +100.00%*·Rev n/aQ2 25EPS +4.56%·Rev n/a⚠ consensus missing

RESMED INC RSMDF

Sallilyn Schwartz — Investor Relations or Corporate Communications

Michael Farrell — Chief Executive Officer

Brett Sandercock — Chief Financial Officer

−1.2%1d on move date−0.7% vs SPY3d−4.5%5d−2.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RSMDF calls or request research access.

More RSMDF calls Browse calls Request research access